OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cardiorenal Protection in Diabetic Kidney Disease
Jason F. Lee, Ecaterina Berzan, Vikas S. Sridhar, et al.
Endocrinology and Metabolism (2021) Vol. 36, Iss. 2, pp. 256-269
Open Access | Times Cited: 13
Jason F. Lee, Ecaterina Berzan, Vikas S. Sridhar, et al.
Endocrinology and Metabolism (2021) Vol. 36, Iss. 2, pp. 256-269
Open Access | Times Cited: 13
Showing 13 citing articles:
Sodium-Glucose Cotransporter 2 Inhibitors Mechanisms of Action: A Review
Jorge I. Fonseca‐Correa, Ricardo Correa‐Rotter
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 153
Jorge I. Fonseca‐Correa, Ricardo Correa‐Rotter
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 153
Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease
Dong‐Lim Kim, Seung‐Eun Lee, Nan Hee Kim
Endocrinology and Metabolism (2023) Vol. 38, Iss. 1, pp. 43-55
Open Access | Times Cited: 27
Dong‐Lim Kim, Seung‐Eun Lee, Nan Hee Kim
Endocrinology and Metabolism (2023) Vol. 38, Iss. 1, pp. 43-55
Open Access | Times Cited: 27
Nonsteroidal mineralocorticoid receptor antagonism for cardiovascular and renal disorders − New perspectives for combination therapy
Peter Kolkhof, Amer Joseph, Ulrich Kintscher
Pharmacological Research (2021) Vol. 172, pp. 105859-105859
Open Access | Times Cited: 56
Peter Kolkhof, Amer Joseph, Ulrich Kintscher
Pharmacological Research (2021) Vol. 172, pp. 105859-105859
Open Access | Times Cited: 56
SGLT2 and DPP4 inhibitors improve Alzheimer’s disease–like pathology and cognitive function through distinct mechanisms in a T2D–AD mouse model
Adelene Y. L. Sim, Da Hyun Choi, Jong Youl Kim, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115755-115755
Open Access | Times Cited: 17
Adelene Y. L. Sim, Da Hyun Choi, Jong Youl Kim, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115755-115755
Open Access | Times Cited: 17
Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis
Eun Sil Koh, Gheun‐Ho Kim, Sungjin Chung
Endocrinology and Metabolism (2023) Vol. 38, Iss. 4, pp. 359-372
Open Access | Times Cited: 13
Eun Sil Koh, Gheun‐Ho Kim, Sungjin Chung
Endocrinology and Metabolism (2023) Vol. 38, Iss. 4, pp. 359-372
Open Access | Times Cited: 13
Sodium‐Glucose Cotransporter 2 Inhibitors, All‐Cause Mortality, and Cardiovascular Outcomes in Adults with Type 2 Diabetes: A Bayesian Meta‐Analysis and Meta‐Regression
Ayodele Odutayo, Bruno R. da Costa, Tiago Pereira, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 18
Open Access | Times Cited: 19
Ayodele Odutayo, Bruno R. da Costa, Tiago Pereira, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 18
Open Access | Times Cited: 19
The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials
Mustafa Kemal Arıcı, Bulent Altun, Mustafa Araz, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Mustafa Kemal Arıcı, Bulent Altun, Mustafa Araz, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Finerenone: A Potential Treatment for Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus
Luis D’Marco, María Jesús Puchades, Lorena Gandía, et al.
touchREVIEWS in Endocrinology (2021) Vol. 17, Iss. 2, pp. 84-84
Open Access | Times Cited: 11
Luis D’Marco, María Jesús Puchades, Lorena Gandía, et al.
touchREVIEWS in Endocrinology (2021) Vol. 17, Iss. 2, pp. 84-84
Open Access | Times Cited: 11
Narrative review investigating the nephroprotective mechanisms of sodium glucose cotransporter type 2 inhibitors in diabetic and nondiabetic patients with chronic kidney disease
Emma S. Speedtsberg, Martin Tepel
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 2
Emma S. Speedtsberg, Martin Tepel
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 2
Expert Opinion on Fixed Dose Combination of Dapagliflozin Plus Sitagliptin for Unmet Cardiovascular Benefits in Type 2 Diabetes Mellitus
Soumitra Ray, Ezhilan Janakiraman, Rajiv Karnik, et al.
Journal of Diabetology (2024) Vol. 15, Iss. 2, pp. 131-141
Open Access
Soumitra Ray, Ezhilan Janakiraman, Rajiv Karnik, et al.
Journal of Diabetology (2024) Vol. 15, Iss. 2, pp. 131-141
Open Access
Új terápiás stratégiák a diabéteszes vesebetegség kezelésében
Zoltán Balogh
Diabetologia Hungarica (2022) Vol. 30, Iss. 5, pp. 351-358
Open Access | Times Cited: 1
Zoltán Balogh
Diabetologia Hungarica (2022) Vol. 30, Iss. 5, pp. 351-358
Open Access | Times Cited: 1
Relative and Absolute Risks of Adverse Events with Real-World Use of SGLT2 Inhibitors in CKD
Ayodele Odutayo, Adeera Levin
Clinical Journal of the American Society of Nephrology (2023) Vol. 18, Iss. 5, pp. 557-559
Open Access
Ayodele Odutayo, Adeera Levin
Clinical Journal of the American Society of Nephrology (2023) Vol. 18, Iss. 5, pp. 557-559
Open Access
Management of CKD
Nimrit Goraya, Jennifer D. Moran
Nephrology Self-Assessment Program (2022) Vol. 21, Iss. 2, pp. 146-167
Closed Access
Nimrit Goraya, Jennifer D. Moran
Nephrology Self-Assessment Program (2022) Vol. 21, Iss. 2, pp. 146-167
Closed Access
